Literature DB >> 15167892

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor.

Jennifer Stamos1, Robert A Lazarus, Xiaoyi Yao, Daniel Kirchhofer, Christian Wiesmann.   

Abstract

The Met tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), play important roles in normal development and in tumor growth and metastasis. HGF-dependent signaling requires proteolysis from an inactive single-chain precursor into an active alpha/beta-heterodimer. We show that the serine protease-like HGF beta-chain alone binds Met, and report its crystal structure in complex with the Sema and PSI domain of the Met receptor. The Met Sema domain folds into a seven-bladed beta-propeller, where the bottom face of blades 2 and 3 binds to the HGF beta-chain 'active site region'. Mutation of HGF residues in the area that constitutes the active site region in related serine proteases significantly impairs HGF beta binding to Met. Key binding loops in this interface undergo conformational rearrangements upon maturation and explain the necessity of proteolytic cleavage for proper HGF signaling. A crystallographic dimer interface between two HGF beta-chains brings two HGF beta:Met complexes together, suggesting a possible mechanism of Met receptor dimerization and activation by HGF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167892      PMCID: PMC423285          DOI: 10.1038/sj.emboj.7600243

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.

Authors:  Ermanno Gherardi; Mark E Youles; Ricardo N Miguel; Tom L Blundell; Luisa Iamele; Julian Gough; Abhishek Bandyopadhyay; Guido Hartmann; P Jonathan G Butler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

Review 2.  Met, metastasis, motility and more.

Authors:  Carmen Birchmeier; Walter Birchmeier; Ermanno Gherardi; George F Vande Woude
Journal:  Nat Rev Mol Cell Biol       Date:  2003-12       Impact factor: 94.444

3.  Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation.

Authors:  S T Freer; J Kraut; J D Robertus; H T Wright; N H Xuong
Journal:  Biochemistry       Date:  1970-04-28       Impact factor: 3.162

4.  Plexin: a novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions.

Authors:  K Ohta; A Mizutani; A Kawakami; Y Murakami; Y Kasuya; S Takagi; H Tanaka; H Fujisawa
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

5.  Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).

Authors:  L E Donate; E Gherardi; N Srinivasan; R Sowdhamini; S Aparicio; T L Blundell
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

6.  Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity.

Authors:  V Cioce; K G Csaky; A M Chan; D P Bottaro; W G Taylor; R Jensen; S A Aaronson; J S Rubin
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

7.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

8.  c-Met expression in tall cell variant papillary carcinoma of the thyroid.

Authors:  Heather C Nardone; Amy F Ziober; Virginia A LiVolsi; Susan J Mandel; Zubair W Baloch; Randal S Weber; Rosemarie Mick; Barry L Ziober
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

9.  Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.

Authors:  Kacper Jankowski; Magda Kucia; Marcin Wysoczynski; Ryan Reca; Dongling Zhao; Ela Trzyna; John Trent; Stephen Peiper; Marek Zembala; Janina Ratajczak; Peter Houghton; Anna Janowska-Wieczorek; Mariusz Z Ratajczak
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  Mode of receptor binding and activation by plasminogen-related growth factors.

Authors:  M Miller; E J Leonard
Journal:  FEBS Lett       Date:  1998-06-05       Impact factor: 4.124

View more
  94 in total

Review 1.  Role of MetMAb (OA-5D5) in c-MET active lung malignancies.

Authors:  Mosmi Surati; Premal Patel; Amy Peterson; Ravi Salgia
Journal:  Expert Opin Biol Ther       Date:  2011-12       Impact factor: 4.388

2.  Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis.

Authors:  Hiroyuki Ohnishi; Kiyomasa Oka; Shinya Mizuno; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

3.  Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1.

Authors:  Heli Liu; Z Sean Juo; Ann Hye-Ryong Shim; Pamela J Focia; Xiaoyan Chen; K Christopher Garcia; Xiaolin He
Journal:  Cell       Date:  2010-08-19       Impact factor: 41.582

Review 4.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

5.  Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase.

Authors:  Weiru Wang; Adhirai Marimuthu; James Tsai; Abhinav Kumar; Heike I Krupka; Chao Zhang; Ben Powell; Yoshihisa Suzuki; Hoa Nguyen; Maryam Tabrizizad; Catherine Luu; Brian L West
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

Review 6.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

7.  An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.

Authors:  Kyle E Landgraf; Micah Steffek; Clifford Quan; Jeffrey Tom; Christine Yu; Lydia Santell; Henry R Maun; Charles Eigenbrot; Robert A Lazarus
Journal:  Nat Chem Biol       Date:  2014-05-25       Impact factor: 15.040

8.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

9.  Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B.

Authors:  Xiu Gao; Marta Lorinczi; Kristen S Hill; Natasha C Brooks; Hatem Dokainish; Keith Ireton; Lisa A Elferink
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

10.  HGF and MET mutations in primary and secondary lymphedema.

Authors:  David N Finegold; Vivien Schacht; Mark A Kimak; Elizabeth C Lawrence; Etelka Foeldi; Jenny M Karlsson; Catherine J Baty; Robert E Ferrell
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.